KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Times Interest Earned (2016 - 2017)

Historic Times Interest Earned for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Q4 2017 value amounting to $0.0.

  • Teva Pharmaceutical Industries' Times Interest Earned rose 10001.05% to $0.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $0.0, marking a year-over-year increase of 27618.54%. This contributed to the annual value of $2.31 for FY2025, which is 84770.39% up from last year.
  • Teva Pharmaceutical Industries' Times Interest Earned amounted to $0.0 in Q4 2017, which was up 10001.05% from $0.0 recorded in Q3 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' Times Interest Earned registered a high of $16.15 during Q2 2015, and its lowest value of -$6.58 during Q2 2013.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Times Interest Earned value was $4.66 (recorded in 2017), while the average stood at $6.21.
  • Within the past 5 years, the most significant YoY rise in Teva Pharmaceutical Industries' Times Interest Earned was 138230.26% (2013), while the steepest drop was 16342.35% (2013).
  • Over the past 5 years, Teva Pharmaceutical Industries' Times Interest Earned (Quarter) stood at $9.49 in 2013, then surged by 41.78% to $13.46 in 2014, then decreased by 1.17% to $13.3 in 2015, then crashed by 101.33% to -$0.18 in 2016, then surged by 100.01% to $0.0 in 2017.
  • Its Times Interest Earned was $0.0 in Q4 2017, compared to $0.0 in Q3 2017 and -$0.0 in Q2 2017.